Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ademetionine 1,4 - Butanedisulfonate for injection

Approval Number

国药准字H20244834

Company武汉启瑞药业有限公司

Registration Date

September 10, 2024

Drug Information

Generic Name

注射用丁二磺酸腺苷蛋氨酸

Dosage Form

注射剂

Strength

0.5g（按腺苷蛋氨酸计）

Drug Type

化学药品

Registration Date

September 10, 2024

Company Information

Applicant Company

Company Name武汉启瑞药业有限公司

Company Address

武汉东湖新技术开发区庙山小区

Manufacturing Company

Company Name武汉启瑞药业有限公司

Company Address

湖北省武汉市东湖新技术开发区庙山小区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用丁二磺酸腺苷蛋氨酸 - NMPA 批准文号 | MedPath